Solesence names Kevin Cureton as its new president and CEO.
Leadership Changes: Solesence has appointed Kevin Cureton as President and CEO and Laura Riffner as CFO, while former CEO Jess Jankowski transitions to Board Advisor until his retirement in November 2025.
Strategic Transformation: These leadership changes are part of a broader strategic transformation following the company's rebranding from Nanophase Technologies and its recent uplisting to Nasdaq, aimed at enhancing visibility and shareholder value.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on SLSN
About SLSN
About the author

Nanophase Technologies GAAP EPS of $0.04, revenue of $20.4M
Financial Performance: Nanophase Technologies reported a Q2 GAAP EPS of $0.04 and revenue of $20.4 million.
Market Developments: Solesence, Inc. is experiencing growth but faces stock price challenges, while other materials stocks are joining the Russell Microcap Index.

Solésence Expands Debt Facilities to Fuel Growth Initiatives
Loan Agreement Amendments: Solésence, Inc. has amended its loan agreements to increase borrowing capacity from $14.2 million to $23.0 million and extended the maturity date to April 30, 2027, providing financial flexibility for strategic objectives.
Company Overview: Solésence is a leader in health care solutions within beauty and life sciences, focusing on innovative mineral-based sun protection and empowering brand partners through enhanced product offerings.









